a blurb in a magazine isn't the most credible source of information...
Now in regards to soy being suggested for treatment of prostate cancer--- It really doesn't help... read...
Minimal effect of a low-fat/high soy diet for asymptomatic, hormonally naive prostate cancer patients.
Spentzos D, Mantzoros C, Regan MM, Morrissey ME, Duggan S, Flickner-Garvey S, McCormick H, DeWolf W, Balk S, Bubley GJ.
Divisions of Hematology/Oncology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA.
PURPOSE: The effects of a low-fat diet or a low-fat diet with the addition of a soy supplement were investigated in a pilot Phase II study for asymptomatic, hormonally naive prostate cancer patients with rising prostate-specific antigen (PSA) levels. Experimental Design: A two-step intervention was implemented. During step 1 patients were begun on a low-fat diet with a goal to reduce fat intake to 15% of total daily calories. On PSA progression, a soy protein supplement was added to the diet (step 2). The primary end point was PSA reduction by 50%. Secondary end points were PSA doubling time and time to progression (TTP). Serum was analyzed for changes in the sex hormone and insulin-like growth factor (IGF-I) axes. RESULTS: Among 18 evaluable patients, (median follow-up on study 10.5 months), no patient on either step had a PSA reduction by 50% at any time. There was a trend toward a longer PSA doubling time (P = 0.06) and a prolongation in estimated median TTP of approximately 3 months (P = 0.018) during step 2 compared with step 1 of the study. During step 1, free testosterone levels decreased by 5% (P < 0.01), and during step 2, IGF-I levels increased by 22% (P = 0.02). CONCLUSIONS: A low-fat diet with the subsequent addition of a soy supplement did not result in a significant decline in PSA levels. The addition of soy protein had a modest effect on TTP. A potentially undesirable effect associated with the administration of soy was an increase in IGF-1 serum levels.
PMID: 12960113 [PubMed - in process]
however, they did notice an increase in IGF-1, bad for people with prostate cancer, not bad for bodybuilders or people without cancer.. however since they do not get into how substantial this is, don't bother considering it for the time being.
here we go, soy isoflavone effect on women...
Effect of soy supplementation on endogenous hormones in postmenopausal women.
Foth D, Nawroth F.
Department of Obstetrics and Gynecology, University of Cologne, Cologne, Germany. [email protected]
AIM: The purpose of this study was to investigate the effect of soy supplementation with isoflavones on plasma hormone levels in postmenopausal women. METHODS: 16 postmenopausal women (mean age 56.21 +/- 5.01 years) were assigned to 24 weeks of dietary soy supplementation. A defined soy protein amount per day (20 g) with a low dosage of isoflavones (20 mg) was used. Plasma samples were analyzed for estradiol, FSH, LH, prolactin, testosterone and DHEAS. RESULTS: After 24 weeks of soy supplementation, plasma levels of estradiol did not increase. Gonadotropins, prolactin and the measured plasma androgens remained unchanged. We did not see any significant treatment effects. CONCLUSIONS: In the postmenopausal hypoestrogenic situation, soy protein consumption with low isoflavones does not influence endogenous hormone levels of estradiol and gonadotropins. Copyright 2003 S. Karger AG, Basel
PMID: 12865591 [PubMed - indexed for MEDLINE]
no effect noted on hormone levels.
here we go, soy milk intake effect on men...
oy milk intake in relation to serum sex hormone levels in British men.
Allen NE, Appleby PN, Davey GK, Key TJ.
Cancer Research UK Epidemiology Unit, University of Oxford, Oxford OX2 6HE, UK. [email protected]
Soy beans contain high levels of the isoflavones genistein and daidzein and their glycosides and have been implicated in the prevention of prostate cancer, possibly via their effects on sex hormone metabolism. The aim of this study was to assess the relation between dietary soy intake and sex hormone levels in a cross-sectional analysis of 696 men with a wide range of soy intakes. Soy milk intake was measured using a validated semiquantitative food frequency questionnaire, and serum hormone concentrations were measured by immunoassay. Multiple regression was used to investigate the association between soy milk intake, an index of isoflavone intake, and hormone levels after adjustment for pertinent confounders. Soy milk intake was not associated with serum concentrations of testosterone, free testosterone, androstanediol glucuronide, sex hormone-binding globulin, or luteinizing hormone. These results suggest that soy milk intake, as a marker of isoflavone intake, is not associated with serum sex hormone concentrations among free-living Western men.
Now, people often think, that because it contains phytoestrogens... people hear the word estrogen and they freak out, usually most accept these articles bashing it without consideration.
Why?
because it's not a tradition in the american life style, so easily dismissed, and all those that do drink it can be classified as 'wierdos' or 'girly' because they are not like the rest..
Infact the phytoestrogens in soy are very weak, they do bind to both estrogen receptors alpha and beta; however, they exert anti-estrogenic effects on ER-alpha (they bind and are far too weak to cause any mammary duct growth or any estrogen hormone related side effects, and since they are occupying the ER's.
Guess what? estradiol and other potent estrogens are in competition to bind!
Sound familiar?
Yes, it should if you knew anyone using tamoxifen, or even among bodybuilders, when infact few bodybuilders know tamoxifen and clomid are really weak synthetic estrogens, quite like soy...
Now let's get to the issue of the effects on ER-beta.
ER-beta you ask?
Well, to some it's new... researches for many years only knew of ER-alpha, but ER-beta predominates in ER responsive tissues, such as bone and the bladder. phytoestrogens exert more effect, though still little among these tissues, which is good, not bad, however little it be, as well as positive effects on lipid levels.
Maybe you think Bullshit?
Don't believe me?
This is fair, but let's examine a recent study...
Relationship between estrogen receptor-binding and estrogenic activities of environmental estrogens and suppression by flavonoids.
Han DH, Denison MS, Tachibana H, Yamada K.
Department of Environmental Toxicology, University of California, Davis 95616-8588, USA. [email protected]
In this study, we investigated the estrogenic activity of environmental estrogens by a competition binding assay using a human recombinant estrogens receptor (hERbeta) and by a proliferation assay using MCF-7 cells and a sulforhodamine-B assay. In the binding assay, pharmaceuticals had a stronger binding activity to hERbeta than that of some phytoestrogens (coumestrol, daidzein, genistein, luteolin, chrysin, flavone, and naringenin) or industrial chemicals, but phytoestrogens such as coumestrol had a binding activity as strong as pharmaceuticals such as 17alpha-ethynylestradiol (EE), tamoxifen (Tam), and mestranol. In the proliferation assay, pharmaceuticals such as diethylstilbestrol, EE, Tam, and clomiphene, and industrial chemicals such as 4-nonylphenol, bisphenol A, and 4-dihydroxybiphenyl had a proliferation-stimulating activity as strong as 17beta-estradiol (ES). In addition, we found that phytoestrogens such as coumestrol, daidzein, luteolin, and quercetin exerted a proliferation stimulating activity as strong as ES. Furthermore, we examined the suppression of proliferation-stimulating activity, induced by environmental estrogen, by flavonoids, such as daidzein, genistein, quercetin, and luteolin, and found that these flavonoids suppressed the induction of the proliferation-stimulating activity of environmental estrogens. The suppressive effect of flavonoids suggests that these compounds have anti-estrogenic and anti-cancer activities.
Speculation to many of these issues is a thing of the past, I suggest some read up on some newer research if giving opinions on the matter, unstead of referencing articles based on old research on rats.
*note I used no rat or mice research hahhaa...